This downturn is primarily attributed to a continued increase in medical costs for government-backed insurance plans, ...

Centene reported $42.5 billion in premium and service revenue for the quarter. However, adjusted EPS came in at a loss of ...

Centene Corporation (NYSE:CNC) is one of the stocks that look extremely cheap on paper. On July 15, 2025, Oppenheimer ...

Our analysis of options history for Centene CNC revealed 12 unusual trades. Delving into the details, we found 58% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Centene ( NYSE: CNC) has been downgraded to Neutral from Overweight at Cantor citing heightened uncertainty in the company's ...

The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...

Debt Management: Centene's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.66. Understanding the Relevance of Analyst Ratings ...

Centene’s stock has been in a free fall since early this month when the St. Louis-based payer pulled its earnings guidance for 2025 citing unexpectedly high spending on its ACA and Medicaid members.

So, where does this position Centene’s stock price? Currently trading around $43 in after-hours markets, CNC is now valued at less than 6 times its trailing adjusted earnings of $7.74 per share.

By Christy Santhosh (Reuters) -Centene shares tumbled 38% on Wednesday, on track for their largest single-day plunge, after the U.S. health insurer pulled its 2025 earnings forecast due to an ...

J.P. Morgan analyst John Stansel downgraded Centene's stock to neutral from overweight, as it remains unclear how the company will be able to correct its healthcare pricing in 2026, given the ...